Chemotherapy-induced Nausea And Vomiting (CINV)

Olanzapine Efficacious for Treatment of Breakthrough CINV

Olanzapine Efficacious for Treatment of Breakthrough CINV

By

This study compared the effectiveness of olazapine, palonosetron, and ondansetron in the treatment of CINV in patients receiving HSCT who are refractory to prophylactic antiemetic agents.

Overuse of Antiemetics Prevalent Among Patients Receiving Low Emetogenic Chemo

Overuse of Antiemetics Prevalent Among Patients Receiving Low Emetogenic Chemo

By

Antiemetic overuse is prevalent among patients with cancer receiving emetogenic chemotherapy and leads to unnecessary spending.

Rolapitant Improves CINV Prevention in Patients With GI Cancers

Rolapitant Improves CINV Prevention in Patients With GI Cancers

By

Adding rolapitant to a 5-HT3 receptor antagonist and dexamethasone significantly improved the prevention of CINV in patients with GI and CRC cancers receiving highly or moderately emetogenic chemotherapy.

MASCC Updates Guidelines for CINV Prevention in Children

By

The Multinational Association of Supportive Care in Cancer and the European Society for Medical Oncology updated their 2009 consensus recommendations for the prevention of acute CINV in pediatric patients with cancer.

Using Olanzapine as an Antiemetic for Patients Undergoing Moderate or High-Emetic Risk Chemotherapy

Using Olanzapine as an Antiemetic for Patients Undergoing Moderate or High-Emetic Risk Chemotherapy

By

Some of our patients receive olanzapine (Zyprexa) as an antiemetic. Is this a typical use of this drug?

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs